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Abstract
Objectives. In some chronic conditions, patient-specific tools with individualized items have proved to be
more sensitive outcome instruments than fixed-item tools; their use has not yet been investigated in
chronic low back pain (cLBP).
Methods. Eleven males and 21 females [mean age 44.0 (12.3) years] with cLBP, undergoing a
spine-stabilization physiotherapy programme, completed the Roland Morris (RM) Disability Scale and a
0–10 pain scale pre- and post-therapy. Post-therapy, goal attainment scaling (GAS) scores were calcu-
lated regarding achievement of 2–6 priority GAS goals established pre-therapy; global outcome of therapy
was assessed on a 5-point Likert scale.
Results. Approximately one-fifth of the individualized goals were not covered by items of the RM. Of the
121 individualized goals, 41 (34%) were achieved at the expected level, 42 (35%) were exceeded and
38 (31%) were not reached. GAS scores correlated with change scores for pain (r= 0.61, P< 0.0001) and
RM (r= 0.49, P= 0.006). Sixty-five per cent of the patients had a successful outcome according to GAS
(i.e. a score 550); 55%, according to global outcome (therapy helped/helped a lot); 39%, according to the
RM score change (score decrease 530%); and 44%, according to the pain score change (score decrease
530%).
Conclusions. GAS demonstrates the achievement of important goals undetected by fixed-item measures
and is a valid and sensitive outcome measure for assessing the success of rehabilitation in patients with
cLBP.
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Introduction
Consideration of the patient’s perspective in the planning
of therapy is associated with greater adherence [1] and
increased satisfaction with care [2]. Similarly, outcome
measures that are patient centred provide the best indi-
cation of the success of treatment. In the field of low back
pain (LBP), fixed-item condition-specific instruments such
as the Oswestry Disability Index [3] and the Roland Morris
(RM) Disability Questionnaire [4] are commonly used to
this end. In some fields of rehabilitation medicine, it has
been shown that wide inter-individual variability in the
manifestations of a given disorder leads to reduced re-
sponsiveness of fixed-item instruments; in contrast, indi-
vidualized outcome measures allow the achievement of
important goals to be demonstrated [5]. Goal attainment
scaling (GAS) [6] is one such instrument that overcomes
the ‘one size fits all’ limitation of fixed-item instruments by
measuring programme success using individualized pa-
tient goals. The instrument has not been investigated
within the context of non-specific chronic LBP (cLBP), a
condition with differing causes and associated disability.
Assessed with traditional outcome measures, the treat-
ment of cLBP is associated with only small to moderate
effect sizes [7]; this is sometimes attributed to the failure
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of trials to consider the heterogeneous aetiology of LBP
resulting in the group treatment effect being ‘diluted
down’ by the inclusion of ‘inappropriate’ patients [8].
However, it is also possible that a lack of specificity in
the outcome measures is partly responsible. This pilot
study assessed the use of GAS in measuring treatment
success as compared with the RM and a pain scale after a
programme of physiotherapy exercises for patients with
cLBP.
Patients and methods
Thirty-seven patients with cLBP participated in the study,
which was part of a broader investigation of various as-
pects of deep trunk muscle function in cLBP [9]. Briefly,
the patients were enrolled into the study before their com-
mencement of a programme of ‘spinal segmental stabil-
ization exercise therapy’ in tertiary care physiotherapy
outpatient departments. They were all diagnosed by
their referring physician as having non-specific cLBP ac-
cording to the diagnostic triage reported in the current
European guidelines [10]. The study was approved by
the medical ethics committee of the Canton of Zu¨rich.
The patients gave their signed informed consent to par-
ticipate after receiving verbal and written information
about the study.
Therapy
Twelve specially trained physiotherapists administered
the treatment once per week for 9 weeks; it was based
on the methods described by Richardson et al. [11] and
involved the preferential activation of the deep abdominal
muscles, using the abdominal drawing-in manoeuvre.
After mastering the basic exercise, patients integrated
the deep trunk muscle contractions into their activities of
daily living or sport. Patients performed home exercises
comprising 10 repetitions, 10 times a day, documented in
an exercise diary.
Questionnaires
Approximately 1–2 weeks before and 1–2 weeks after
therapy, the patients completed a questionnaire contain-
ing (in addition to socio-demographic, medical and pain
history questions):
. RM Disability Scale, which measures 24-activity limi-
tations due to back pain (score 0–24: higher score,
increased disability) [4]; and
. Pain Graphic Rating Scale (pain) [12]: a 0–10 scale to
record average back pain intensity during the last
week.
After therapy further questions inquired about the global
outcome of treatment {‘overall, how much did the treat-
ment you received in the last few months help?’, with a
5-item Likert scale dichotomized for describing the suc-
cess of the treatment into ‘good outcome’ (‘helped’ or
‘helped a lot’) or ‘poor’ (‘helped only little’, ‘didn’t help’,
‘made things worse’) [13]} and the changes that had taken
place since before therapy in relation to back pain,
independence in everyday activities, ability to do sport,
general physical capacity (at home or work), frequency
and quality of social contacts and mental well-being [13]
(response options: much better, better, unchanged, worse
and much worse).
GAS
GAS was implemented in accordance with the original
model described by Kiresuk and Sherman [6]. According
to a recent systematic review, GAS delivers reliable and
valid scores when employed as an outcome measure in
working age and older people within a physical and neuro-
logical rehabilitation environment [14]. Before therapy, two
to five goals were chosen through negotiation and con-
sensus between the treating physiotherapist and the pa-
tient; for each goal, five levels of possible outcome were
specified. The goals were to be specific, measurable,
achievable, realistic and timed (SMART) [5, 6]. A score
of 1 indicated where the patient saw himself at baseline,
i.e. pretreatment. After treatment, each goal was exam-
ined by the corresponding treating therapist together with
the patient and its relative achievement rated as follows:
at the expected level (score of 0), less than expected
(1, no change from baseline; 2, much less than base-
line) or more than expected (+1, more; +2, much more).
The scores were then converted to a GAS T-score,
using the formula provided by Kiresuk et al. [15], and in-
terpreted as follows: 50, expected level of achievement;
<50, performance below the expected level; >50, per-
formance above the expected level. A content analysis
was carried out to investigate how many of the individual
GAS goals were reflected in the items in the RM.
Statistical analysis
Descriptive data are presented as means (S.D.) or
medians [interquartile range (IQR)], as appropriate.
Responsiveness was given by the standardized response
mean [SRM = (post-test meanpre-test mean)/S.D.
changes]. The relationships between GAS scores and
the change scores for RM disability and pain were exam-
ined using partial correlation coefficients, holding baseline
values for these variables constant, as recommended by
Heavlin et al. [16]. Significance was accepted at the 5%
level, with no corrections for multiple testing [17].
Results
Of the 37 patients, 32 (86%) completed the physiotherapy
programme and questionnaires. Five patients were con-
sidered dropouts: two had never actually fulfilled the
study’s admission criteria (one language, one medical)
and three chose not to continue due to the time
commitment.
The baseline characteristics and main outcome results
for the 32 completers have been reported elsewhere [9].
Briefly, there were 11 men and 21 women and their mean
age was 44.0 (S.D. 12.3) years. They had had LBP on aver-
age for 92 (S.D. 129) months and had an RM disability
score of 8.9 (S.D. 4.7), and an average pain intensity of
www.rheumatology.oxfordjournals.org 1735
Goal attainment scaling as an outcome in cLBP
4.7 (S.D. 1.7). The main outcomes after therapy comprised
a 2.3 (S.D. 4.2) point reduction in RM disability and a 1.1
(S.D. 2.1) point reduction in average pain (each P< 0.01);
these constituted SRMs of 0.54 and 0.53, respectively [9].
In total, 134 individual goals were recorded for the
whole group before the treatment began [median 4 (IQR
2; range 2–5) goals/patient]. With a score of 1 attributed
to each GAS item pretreatment, the group mean baseline
GAS score was 35.7 (S.D. 1.0).
The proportion of goals related to each of the RM items
is shown in Table 1. Nine RM items did not feature in any
of the GAS goals. Altogether, 105 (78%) of 134 goals
could be matched to an RM item; those that could not
tended to be related to sporting performance, work or
psychological factors.
After therapy, it was possible to assess the level of
achievement for 121 of the original 134 goal sets (goals
from the dropouts, or goals related to seasonal sports, or
influenced by subsequent musculoskeletal injuries, could
not be assessed after therapy): 41 (34%) were achieved
at the expected level; 38 (31%) were not reached and
42 (35%) were exceeded.
The mean GAS score after treatment was 51.0 (S.D.
13.7; range 24.6–80.2). This represented a mean change
from pretreatment of 15.3 (S.D. 13.9), giving a SRM for the
GAS of 1.10.
The GAS scores correlated with the change in pain (cor-
rected for baseline pain; partial r= 0.61, P< 0.0001) and
RM (corrected for baseline disability; partial r= 0.49,
P= 0.006), and with the post-therapy ratings of global
treatment effectiveness (corrected = 0.39, P= 0.034).
They also showed low but significant correlations with
the post-therapy ratings of improvement in the domains
back pain, independence, ability to do sport and mental
well-being (Table 2).
The proportions of patients achieving a minimum 30%
reduction in RM and in pain (i.e. clinically relevant changes
[18]) were 39 and 44%, respectively. The global outcome
was rated as ‘good’ (therapy helped/helped a lot) in 55%
of patients. The proportion of patients who achieved or
exceeded their goals, as judged by a GAS score 550,
was 64.5%.
Discussion
A major challenge in the evaluation of treatment outcome
is the identification of methods that adequately measure
the success of a programme. Clinicians have long sought
standardized tests against which an entire patient popu-
lation can be measured; equally, however, such measures
are criticized for being insensitive to the uniqueness of the
goals of each patient within a given programme [19].
Overall, the findings of the present study supported
those in other fields of rehabilitation, namely that there
was a moderate correlation between the scores given by
the fixed-item and patient-specific measures (suggesting
adequate construct validity for the GAS), but that GAS
TABLE 1 Frequency of items in the RM disability questionnaire that featured as the area to be addressed in the
individual’s goals
RM item no. Item content Count, n (%)
2 I change position frequently to try and get my back comfortable 21 (15.7)
10 I only stand up for short periods of time because of my back 15 (11.2)
11 Because of my back I try not to bend or kneel down 15 (11.2)
4 Because of my back I am not doing any of the jobs that I usually do around the house 13 (9.7)
21 I avoid heavy jobs around the house because of my back 11 (8.2)
17 I only walk short distances because of my pain 9 (6.7)
13 My back is painful almost all the time 5 (3.7)
18 I sleep less well because of my back 5 (3.7)
14 I find it difficult to turn over in bed because of my back 3 (2.2)
23 Because of my back pain, I am more irritable and bad tempered with people than usual 3 (2.2)
12 I find it difficult to get out of a chair because of my back 2 (1.5)
16 I have trouble putting on my socks (or stockings) because of the pain in my back 1 (0.8)
5 Because of my back I use a handrail to get upstairs 1 (0.8)
3 I walk more slowly than usual because of my back 1 (0.7)
1 I stay at home most of the time because of my back 0 (0)
6 Because of my back I lie down to rest more often 0 (0)
7 Because of my back I have to hold on to something to get out of an easy chair 0 (0)
8 Because of my back I try to get other people to do things for me 0 (0)
9 I get dressed more slowly than usual because of my back 0 (0)
15 My appetite is not very good because of my back pain 0 (0)
19 Because of my back pain I get dressed with help from someone else 0 (0)
20 I sit down for most of the day because of my back 0 (0)
24 Because of my back I go upstairs more slowly than usual 0 (0)
- 29 (21.8)
Total 134 (100)
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was more responsive to change after treatment than were
the fixed-item instruments.
Following the methods reported in previous studies on
GAS (e.g. [5, 20]) and for the purposes of comparison, we
assessed the instrument’s responsiveness using the SRM
(while mindful of the objections to doing so [6]).
Encouragingly, the conclusions based on the SRMs (i.e.
that GAS was the most responsive instrument) were
wholly substantiated by those based on non-parametric
methods of inferential analysis, such as frequency ana-
lysis of the proportion of patients with a successful out-
come. It was established that almost two-thirds (65%) of
the patients had a GAS score 550, indicating that they
had achieved or exceeded their goals, whereas only
40% patients achieved the minimum clinically important
change of a 30% reduction in score for pain or disability,
and 55% reported a ‘good global outcome’. Hence, GAS
does indeed appear to demonstrate the achievement of
important goals that are less well detected by fixed-item
measures.
We attempted to examine the content validity of GAS by
performing a qualitative content analysis of the individual
goals declared pretreatment. At face value, the goals ap-
peared to be typical of those commonly identified in
normal clinical practice for patients of this type. Also,
most of the goals were approximated by the items of
the RM, an instrument devised on the basis of typical
complaints in a large group of LBP patients in primary
care [4]. It was interesting, however, that 22% of the
goals set using the GAS—most notably those to do with
sports, work or psychological manifestations of the
pain—could not be linked to any items of the RM, even
in their broadest context of understanding. This highlights
one of the benefits of GAS, i.e. it is able to obtain a com-
prehensive record of items that are important to the pa-
tients, regardless of how ambitious they may appear to be
on an ‘average patient’ basis. Interestingly, many of the
goals, although expressed in terms of ‘function’, were ac-
tually placed within a context of pain (e.g. 20 minutes
standing without pain); this might explain why the GAS
score correlated better with improvements in pain than
with improvements in RM score. Despite what we might
like to think or hope, it would seem that it is still the level of
pain that is most important to these patients.
One of the potential disadvantages of GAS is that clin-
icians require sufficient knowledge, training and experi-
ence to carry out the procedure of goal setting.
Nonetheless, the various steps in the process are all
well documented [15]. The GAS formula is designed
such that if goal achievement is predicted accurately
and in an unbiased manner, the GAS at outcome should
exceed and fall short of expectations in roughly equal pro-
portions, and there should be an approximately normal
distribution of GAS T-scores with a mean (S.D.) of 50 (10)
[6]. This was the case in the present study [GAS score
51 (14), range 25–80] suggesting that there was no or
little bias in estimating the potential for gain, and providing
some support for the validity of the method applied. To
the authors’ knowledge, the impact of the actual number
of goals set on the subsequent GAS scores has not been
investigated in detail, and within the confines of the pre-
sent study we could not shed any further light on this. The
use of more than two goals is reported to deliver more
reliable scores, as is the use of a 5-point rather than a
3-point scale for rating their achievement, but the
number set must also be considered in relation to the
length and scope of the programme and the needs of
the patient [15]. We were also unable to assess the test–
retest reliability of the GAS scores in the present study;
however, a recent systematic review has testified to the
reliability of GAS when employed as an outcome measure
in other physical rehabilitation settings [14].
Another possible limitation of GAS as an outcome instru-
ment is that it is designed for assessing the effectiveness of
treatment after a designated period of time only. In many
instances, however, it is desirable to follow up patients for
longer to see how well any treatment effect is maintained.
For this, the serial application of fixed-item instruments,
which simply focus on current status at each assessment,
are required. GAS scores also tell us nothing about the
absolute level of adjustment or disability of the individual.
Important decisions regarding the quality of therapy and
health policy are based on patient outcomes, and so it is
essential to identify the most appropriate assessment
tool. Our findings lead us to concur with previous authors
[5, 20] that, in addition to documenting pretreatment ex-
pectations on change and sharpening the focus of treat-
ment, GAS is able to capture subtle but important change
TABLE 2 Spearman’s rank correlation coefficients between the global improvements in each domain measured
post-therapy and the GAS scores, the change scores for pain and change scores for RM disability
Outcome domain GAS score Change score Average LBP Change score RM
Global improvement in pain 0.44 0.51 0.49
Global improvement in independence 0.40 0.59 0.54
Global improvement in ability to do sport 0.43 0.48 0.66
Global improvement in physical activities in general 0.33 0.46 0.50
Global improvement in quality/quantity social contacts 0.01 0.13 0.02
Global improvement in mental well-being 0.40 0.25 0.08
Values in bold are P< 0.05.
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in client-centred functioning. It appears more suited to
complement rather than replace established outcome
measures—since both have their own unique advantages
and disadvantages—and will perhaps have more rele-
vance in one setting than in another. However, overall,
GAS should be considered a useful adjunct to the present
fixed-item options for assessing patient outcomes after
rehabilitation for cLBP.
Rheumatology key messages
. Important decisions regarding therapy and health
policy are based on patient outcomes.
. GAS is able to capture subtle but important
changes in the functioning of patients with LBP.
. GAS appears more suited to complement rather
than replace established fixed-item outcome
measures.
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